Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125314
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2023-11-06
Brief Title:
HER2 TREAT Study Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable andor Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2 |
| Breast Neoplasms |
| Breast Cancer |
| Breast Carcinoma |
| Genes |
Keywords: